- Biotech Stocks Were Tanking. The Cure? M&A. (barrons)
- Inside Saudi Arabia’s $3 Trillion Plan to Move Past Oil (barrons)
- The Fed Faces Multiple Challenges in 2024. Navigating an Election Year Is One. (barrons)
- Prices Fell for the First Time Since 2020. What Was Behind the Drop. (barrons)
- Banks Aren’t Fighting Private Credit—They’re Enabling It (barrons)
- Charlie Munger, Close Up (barrons)
- A record share of S&P 500 stocks underperformed the index in 2023 as ‘weirdest bull market in decades’ marches on (marketwatch)
- Here are the 20 worst-performing stocks among the S&P 500 in 2023 (marketwatch)
- These 4 Economic Indicators Are Key to Watch for Fed Rate Cuts (barrons)
- Why Hertz Stock Could Be a Winner in 2024 (barrons)
- L.A. office building sells for $153.5 million — $115 million less than its sale price a decade ago (marketwatch)
- 11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria (marketwatch)
- Opinion: Tax-loss selling makes these stocks in cannabis, pharma, energy and industrials worth buying (marketwatch)
- Wall Street banks propel Dallas to second behind NYC in number of finance workers (nypost)
- FT writers’ predictions for the world in 2024 (ft)
- Ant Completes Process of Removing Jack Ma’s Control (bloomberg)
- ‘Everyone Got Burned’: Wall Street Missed the Great Stock Rally of 2023 (bloomberg)